These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 166943)

  • 1. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG; Robins RA; Baldwin RW
    Int J Cancer; 1975 Apr; 15(4):640-50. PubMed ID: 166943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.
    Embleton MJ
    Br J Cancer; 1976 Jun; 33(6):584-92. PubMed ID: 181041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.
    Baldwin RW; Bowen JG; Price MR
    Br J Cancer; 1973 Jul; 28(1):16-24. PubMed ID: 4353387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA; Baldwin RW
    Int J Cancer; 1974 Nov; 14(5):589-97. PubMed ID: 4376528
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
    Baldwin RW; Embleton MJ; Robins RA
    Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Correlation of serum levels of hepatoma D23 antigen, antibody and immune complexes with growth of transplanted tumours.
    Price MR; Bowen JG
    Br J Cancer; 1974 Aug; 30(2):183. PubMed ID: 4370885
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum factor levels during the growth of rat hepatoma nodules in the lungs.
    Bowen JG; Baldwin RW
    Int J Cancer; 1976 Feb; 17(2):254-60. PubMed ID: 175030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of the draining and distal lymph nodes during the progressive grwoth of a chemically-induced transplantable rat hepatoma.
    Jones JA; Robinson G; Rees RC; Baldwin RW
    Int J Cancer; 1978 Feb; 21(2):171-8. PubMed ID: 203547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of tumour-specific antigen from the serum of rats bearing transplanted aminoazo dye-induced hepatomas.
    Bowen JG; Baldwin RW
    Transplantation; 1976 Mar; 21(3):213-9. PubMed ID: 59982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of rat hepatoma membrane fractions.
    Baldwin RW; Embleton MJ; Moore M
    Br J Cancer; 1973 Nov; 28(5):389-99. PubMed ID: 4357132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1976 Jan; 17(1):129-37. PubMed ID: 175021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen.
    Price MR; Baldwin RW
    Br J Cancer; 1974 Nov; 30(5):382-93. PubMed ID: 4143271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.
    Höffken K; Price MR; Moore VE; Baldwin RW
    Int J Cancer; 1978 Nov; 22(5):576-82. PubMed ID: 214404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells.
    Shah LP; Rees RC; Baldwin RW
    Br J Cancer; 1976 Jun; 33(6):577-83. PubMed ID: 181040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic properties of rat hepatoma subcellular fractions.
    Price MR; Baldwin RW
    Br J Cancer; 1974 Nov; 30(5):394-400. PubMed ID: 4377707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Baldwin RW; Price MR; Robins RA
    Nat New Biol; 1972 Aug; 238(84):185-6. PubMed ID: 4340574
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours.
    Baldwin RW; Glaves D; Vose BM
    Br J Cancer; 1974 Jan; 29(1):1-10. PubMed ID: 4362448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.